Scientists found that CD4+ Tfh TIL, CD8+ TIL and TIL-B, co-localizing in TLS, all expressed the CXCL13 receptor CXCR5.
[Journal of Clinical Investigation]
6445218
{6445218:K5F3G4DH}
apa
50
1
166045
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/